Hyundai Bioscience Co. Ltd (048410) — Strategic Asset Allocation Index
Hyundai Bioscience Co. Ltd (048410) has a Strategic Asset Allocation Index of 6.0% as of September 2024. Strategic assets (PP&E of ₩2.64 Billion plus long-term investments of ₩-) total ₩2.64 Billion, measured against net assets of ₩43.74 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 048410 net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hyundai Bioscience Co. Ltd Strategic Asset Allocation Index (2002–2022)
This chart shows how Hyundai Bioscience Co. Ltd's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2022. As of September 2024, the index stands at 6.0%, representing strategic assets of ₩2.64 Billion against net assets of ₩43.74 Billion KRW. For live market cap and overall valuation, see Hyundai Bioscience Co. Ltd stock valuation.
Annual Strategic Asset Allocation Index for Hyundai Bioscience Co. Ltd (2002–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Hyundai Bioscience Co. Ltd from 2002 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Hyundai Bioscience Co. Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.9% | ₩6.38 Billion | ₩6.38 Billion | ₩- | ₩58.24 Billion | ▲ +1.1 pp |
| 2021 | 9.9% | ₩6.07 Billion | ₩6.07 Billion | ₩- | ₩61.57 Billion | ▼ -3.2 pp |
| 2020 | 13.0% | ₩6.67 Billion | ₩6.67 Billion | ₩- | ₩51.22 Billion | ▼ -6.5 pp |
| 2019 | 19.5% | ₩9.17 Billion | ₩7.20 Billion | ₩1.97 Billion | ₩46.99 Billion | ▼ -4.0 pp |
| 2018 | 23.5% | ₩9.53 Billion | ₩8.37 Billion | ₩1.16 Billion | ₩40.48 Billion | ▼ -8.9 pp |
| 2017 | 32.4% | ₩10.01 Billion | ₩9.44 Billion | ₩571.51 Million | ₩30.89 Billion | ▼ -27.2 pp |
| 2016 | 59.6% | ₩10.85 Billion | ₩10.08 Billion | ₩773.38 Million | ₩18.21 Billion | ▲ +35.1 pp |
| 2015 | 24.5% | ₩6.02 Billion | ₩5.42 Billion | ₩600.25 Million | ₩24.60 Billion | ▼ -3.6 pp |
| 2014 | 28.1% | ₩6.31 Billion | ₩5.71 Billion | ₩600.25 Million | ₩22.49 Billion | ▲ +1.9 pp |
| 2013 | 26.2% | ₩5.71 Billion | ₩5.71 Billion | ₩- | ₩21.80 Billion | ▼ -11.8 pp |
| 2012 | 37.9% | ₩7.17 Billion | ₩7.17 Billion | ₩- | ₩18.90 Billion | ▲ +1.6 pp |
| 2011 | 36.3% | ₩5.15 Billion | ₩5.15 Billion | ₩- | ₩14.17 Billion | ▲ +15.7 pp |
| 2010 | 20.6% | ₩6.60 Billion | ₩6.60 Billion | ₩- | ₩32.08 Billion | ▲ +1.0 pp |
| 2009 | 19.5% | ₩7.68 Billion | ₩7.68 Billion | ₩- | ₩39.30 Billion | ▲ +5.9 pp |
| 2008 | 13.6% | ₩6.87 Billion | ₩6.87 Billion | ₩- | ₩50.36 Billion | ▲ +5.7 pp |
| 2007 | 8.0% | ₩4.65 Billion | ₩4.65 Billion | ₩- | ₩58.24 Billion | ▼ -35.5 pp |
| 2005 | 43.5% | ₩17.10 Billion | ₩17.10 Billion | ₩- | ₩39.33 Billion | ▲ +11.8 pp |
| 2004 | 31.7% | ₩19.33 Billion | ₩19.33 Billion | ₩- | ₩60.94 Billion | ▲ +5.0 pp |
| 2003 | 26.8% | ₩18.30 Billion | ₩18.30 Billion | ₩- | ₩68.34 Billion | ▼ -3.3 pp |
| 2002 | 30.1% | ₩19.26 Billion | ₩19.26 Billion | ₩- | ₩64.08 Billion | — |